Anti-glycoprotein 2 (anti-GP2) IgA and anti-neutrophil cytoplasmic antibodies to serine proteinase 3 (PR3-ANCA): antibodies to predict severe disease, poor survival and cholangiocarcinoma in primary sclerosing cholangitis.
Ewa WunschGary L NormanMalgorzata MilkiewiczMarcin KrawczykChelsea BentowZakera ShumsMichael MahlerSteffi LopensDirk ReinholdAndre FrankeChristoph SchrammDirk RoggenbuckPiotr MilkiewiczPublished in: Alimentary pharmacology & therapeutics (2020)
Anti-GP2 and PR3-ANCA are prognostic antibodies in PSC as they identify patients at risk of severe disease, poor survival and biliary cancer.